Ablation of Paroxysmal and Persistent Atrial Fibrillation

Size: px
Start display at page:

Download "Ablation of Paroxysmal and Persistent Atrial Fibrillation"

Transcription

1 Ablation of Paroxysmal and Persistent Atrial Fibrillation J.A. Salerno-Uriarte, M. Lanzotti, R. De Ponti, M. Tritto*, G. Spadacini*, R. Marazzi, P. Moretti* Università degli Studi dell'insubria, Dipartimento di Scienze Cardiovascolari "Ospedale di Circolo e Fondazione Macchi" Varese e *Dipartimento di Cardiologia "Mater Domini", Castellanza, Italia. Introduction Atrial fibrillation (AF) is the most common arrhythmia in humans. Its maintenance is thought to be due to multiple wavelets reentry occurring in both atria [1]. Previous studies have demonstrated the feasibility and efficacy of cryoablation to create lesions in both atria [2] and on the posterior wall of the left atrium [3], connecting the four pulmonary veins and the mitral annulus [4], in patients with chronic AF undergoing valvular heart surgery, as a valid alternative to the Maze procedure. Recently, the pulmonary veins (PVs) have been demonstrated to often play an important role in generating atrial fibrillation [5-7]. Because of their critical role in AF, a variety of surgical and catheter ablation techniques has been used to isolate the PVs from the left atrium [8-10]. Initial attempts at linear ablation Following the remarkable success of catheter based ablation techniques in curing supraventricular arrhythmias, the attention of the electrophysiological community has turned upon atrial fibrillation based on the assumption that surgical incisions can be duplicated by a catheter based technique that should provide results equivalent to the Maze procedure. Some studies attempted to intervene in both atria [11-12]; one in a progressive incremental fashion and the other one more directly imitating the surgical Maze with a biatrial approach. Creating continuous linear lesions to duplicate surgical atriotomies was difficult; atrial right lesions alone were safe but usually ineffective; left atrial lesions improved success rates though at a significant morbidity (including proarrhythmic left atrial reentry) and even mortality cost; and both studies showed the feasibility of cure by catheter based techniques in patients with paroxysmal and persistent atrial fibrillation. Recognition of initiation of atrial fibrillation from the pulmonary veins AF initiation has been shown to be due to triggers predominantly clustered within thoracic veins, particularly pulmonary veins (PVs) [5-7] but the reasons for this arrhythmogenic behaviour are unknown. Anatomic studies have demonstrated that the myocardial sleeves that envelope the PVs are most prominent at the left superior, left inferior, and right superior PVs [13]. Moreover, little is known of the electrophysiological characteristics of these veins, particularly focusing of patients with or without AF. Jaïs et al [14] have described specific electrophysiological properties of PVs in humans, distinguishing patients with from those without AF. They performed programmed stimulation from multiple sites and showed that in patients with AF, PV effective refractory periods (ERPs) are significantly shorter than LA ERPs, and significantly shorter than venous ERPs of patients without AF. The PV potential (PVP) functional refractory periods (FRPs) of patients with AF were also significantly shorter than those of control patients, whereas the FRPs of the PV-LA junction and the LA ERPs were comparable, demonstrating that the main difference between patients with and without AF were observed in PVs rather than at the junction with the LA or in the LA itself. These short functional refractory periods may explain why rapid high-frequency activity is consistently recorded in the PV area during AF [10,15]. Electrical properties of the thoracic veins have been assessed in animals [16], but currently, there are no animal models of AF spontaneously induced from PVs, and as a result, few experimental data are available to substantiate these findings. However, action potentials at the distal end of PVs were previously reported to be shorter than those of more proximal segments and LA in guinea pigs [17]. The pronounced decremental conduction properties of PVs may probably explain the marked conduction delay in the PVs observed during AF initiation or ectopic beats, as well as the phenomenon of concealed venous ectopies blocked within the vein [18]. The activation delay was correlated with complex fibber arrangement and particularly with abrupt changes in their direction. These decremental conduction properties could therefore be related to anisotropic conduction [19], with the fractionated venous potentials and associated changes in activation sequence and exits probably correlating with the complex arrangement of venous muscular sleeves reported by pathologists

2 in humans [20]. In association with long conduction times in PVs, these short refractory periods provide a very favourable "milieu" for arrhythmogenicity, particularly reentry in or around the veins, which may perpetuate the arrhythmia and thus act as a substrate for AF maintenance [14]. The exact mechanism of these isolated or multiple discharges culminating in paroxysms of AF is uncertain, hence, the term "discharges". Activation during the interval between the previous sinus beat and the initial venous discharge which would support a reentrant mechanism has not been documented to date and is suggestive of triggered automaticity. The next phase with repetitive discharges (frequently with continuous activity in the PVs) is followed by apparently random PV activation believed to be related to wandering rotors or fleeting re-reentry. A transitional phase of re-entry within or around the PV of origin is a likely possibility particularly since short refractory periods in the PVs coexisting with long conduction times to the left atrium (at typical short coupling intervals) provide a "milieu" conducive to re-entry. Mapping and electrical disconnection of PVs The variety of patients with paroxysmal AF (lasting hours to days), however, has frequent involvement of [2-3] PVs as well as additional non-pulmonary vein initiation sources. Therefore, though initiations from multiple PV sources can be documented by trying different provocative manoeuvres or by restudying a patient at another more opportune moment, a practical approach is to systematically ablate and disconnect the myocardial sleeve of at least 3 PVs. The right inferior PV is frequently difficult to map completely, and perhaps, therefore, its arrhythmogenic potential has been underestimated [6]. Pulmonary vein (PV) isolation can be achieved by segmental ostial ablation guided by PVP recorded during sinus rhythm and/or atrial pacing [8,21]. Targets areas are considered those exhibiting the shortest venoatrial conduction time (in sinus rhythm or distal coronary sinus pacing), as measured from the couple of electrodes of the mapping catheter. De Ponti et al [22] have reported the utility of high -density mapping of the PVs to identify multiple discrete areas of earliest activation along the perimeter of the PV os, which reflect the location of the venoatrial conduction breakthroughs; they also demonstrated different patterns of activation inside the PVs, and that in the majority of the cases, the finding of multiple foci in the PV, in accordance with a prior report by Haïssaguerre et al [23]. Circumferential mapping allows electrophysiological guided disconnection of the PVs to be accomplished with a high success rate. The more proximal the level of ablation for the PVs, the greater the extent of disconnected myocardium, but this requires more extensive ablation because of increasing diameter and myocardial coverage proximally. Electrophysiological sites of preferential "inputs" or "breakthroughs" from the left atrium to the PVs, enable to disconnect at the ostia without circumferential ablation [8]. A circumferential multielectrode catheter (Lasso: Constellation) allows continuous assessment of activation around the complete circumference of the vein in addition to providing a fluoroscopically visible marker for the vein. One of two bipole (s) or electrode (s) typically show earliest activation with later and sequential spread to the rest of the venous circumference. The catheter ablation must be performed proximal to this site. Disappearance of activation in a part of the circumference after proximal ablation suggests the ablation of a fascicle like myocardial extensions. The disappearance of all distal PVs potentials is a clear indicator of conduction block. Electrical disconnection occurs when the PV potentials abruptly disappear or are dissociated from the atrial potentials during RF delivery. It is important to distinguish PVPs from "far field" atrial potentials so as to avoid unnecessary ablations which could result in vein stenosis or avoidable collateral damage (ex. to the phrenic nerve). In the right sided PVs both right as well as left atrial potentials can be identified (by mapping both sides of the interatrial septum), while in the left PVs, the nearby left atrial appendage is the most common origin of non-pvs potentials. In the latest case, distal coronary sinus pacing by anticipating left atrial appendage activation can distinguish the two. Sometimes, the presence of electrical connections between PVs may imply that treatment of contiguous vessels might be required when PV electrical disconnection procedures are attempted [24]. The use of limited radiofrequency power, minimising the circumferential extent of ablation and targeting the most proximal segments may be important in limiting the frequency of complications. Recurrence of AF A recurrence of AF after PV isolation must be caused either by the resumption of PV conduction or by the presence of critical foci outside the PVs. In patients who underwent a second procedure, incomplete isolation of a previously isolated PV is frequently found. Recovery of conduction through inadequately ablated muscle fascicles in the muscle sleeves surrounding the PVs may be the most common reason for recurrent AF after PV isolation, at least among patients with paroxysmal AF. Tritto et al [25] have observed that the recurrences

3 that occurred during the first week after PV isolation are not predictive of an unsuccessful procedure during the follow-up, and may be caused by an irritative or inflammatory process or by the lesion's instability (transient return of atrial-pv conduction that later interrupts spontaneously or by the effect of a previously ineffective antiarrhythmic therapy). After disconnection of the PVs, provocative manoeuvres (isoprenaline and adenosine infusion, incremental atrial pacing) must be performed [26], in order to know their electrophysiological effects on the residual PV musculature and atrio-venous conduction after successful isolation of different PVs. Non PVs sources are found in up to 30% of patients, and are most frequently located in the posterior left atrium and surrounding the ostia of the PVs. Less commonly, there are extra left atrial sources, and may be located epicardically within the coronary sinus; within the vein or ligament of Marshall, or in the right side of the heart, the junction between the superior vena cava to the right atrium. Conclusions Nowadays, pulmonary veins are of major interest as a result of their prominent arrhythmogenic role in AF. In association with long conduction times in PVs, short refractory periods provide a very favourable "milieu" for arrhythmogenicity, particularly reentry in or around the veins, which may perpetuate arrhythmia and thus act as substrate for AF maintenance [14]. De Ponti et al [22] evaluated the activation inside the PVs and identified different patterns, which can be grouped in two fundamental forms: a predominantly longitudinal activation pattern and a predominantly transverse one, that may be correlated with histological data of PVs, reporting the presence of a mesh-like arrangement with a combination of spirally and longitudinally oriented bundles of fibers [27]. Our group [28] have also reported that a subset of patients with AF, even in the absence of an organic heart disease, have an altered atrial conduction on sinus rhythm, as compared to control patients; electroanatomical mapping seems to be able to identify different patterns of altered propagation. PV isolation can be achieved by segmental ostial ablation guided by PV potentials recorded during sinus rhythm and/or atrial pacing [8], and also during atrial fibrillation [29]. Immediate recurrences of atrial fibrillation are consistently abolished by PV isolation, implying that these recurrences are often initiated by depolarisations originating in the PVs. Also, persistent AF became inducible less often as more PVs are isolated, and demonstrates that the PVs are not only a source of the triggers that initiate AF but also may play an important role in the maintenance of AF. In previous studies of segmental PV isolation, only the PVs that were found to generate triggers of AF were isolated, and a large percentage of patients required additional ablation procedures [8,23]. Oral et al [30] have reported a segmental isolation approach that targets at least 3 PVs, with a clinically satisfactory result in more than 80% of patients with paroxysmal AF, and showed that, the clinical efficacy of PV isolation is much lower when AF is persistent than when it is paroxysmal. This empiric approach is not based on identification of which PVs were arrhythmogenic. Of note is that the long-term efficacy of these two approaches is very similar, but a second ablation procedure is more frequently performed with the first approach (41% vs. 9%). Therefore, in patients with paroxysmal AF, more reliable results may be obtained with empiric isolation of all pulmonary veins, than with isolation of only the PVs that seem to be arrhythmogenic during the ablation procedure. These results are similar as the ones reported by our group [31], with 80% of the patients with paroxysmal or persistent AF in sinus rhythm during the follow-up (2.9±3.7 months), with 33% of patients with antiarrhythmic therapy, after a mean of 2.1 PV isolation/procedure. Demonstration of elimination of atrial fibrillation frees the patient not only from antiarrhythmic treatment but also from oral anticoagulation. This procedure although does not eliminate paroxysmal AF in about 30% who typically have non-pv focal sources. Resistance to antiarrhythmic drugs should determine when this therapeutic option should be offered to a specific patient with paroxysmal AF. In conclusion, electrical disconnection of PVs could be performed with clinically satisfactory results, and with a low risk of PV stenosis and thromboembolic complications, which compares favourably with the risk of paroxysmal or persistent atrial fibrillation, and antiarrhythmic or anticoagulant treatment. More than 90% of PVs can be electrically isolated from the left atrium by conventional applications of radiofrequency energy along segments of the ostia, guided by PV potentials. Generally, PVs can be isolated in < 4 hours without creating PV stenosis and with a low risk of other serious complications. A satisfactory clinical outcome, consisting of either complete resolution or marked improvement in symptoms, can be achieved in 85% of patients with paroxysmal atrial fibrillation. When 3 or 4 PVs are isolated, a satisfactory clinical outcome can be

4 achieved in most patients with a single procedure and without the need for antiarrhythmic drug therapy. In contrast to paroxysmal AF, persistent AF usually is not eliminated by PV isolation. Electrical disconnection of PVs in patients with drug-refractory paroxysmal AF should not be postponed until AF becomes persistent. Once AF has become persistent, it is likely that PV isolation will have to be supplemented by some other type of ablation procedure directed at the atrial myocardium. Figure 1: Fluoroscopic image of the left superior pulmonary vein (LSPV) in antero-posterior view. The angiographic catheter is positioned in the vein through transseptal catheterisation Figure 2: Fluoroscopic image of the basket catheter positioning in the same vein and patient as in Figure 1 in antero-posterior view before venography. Figure 3: Fluoroscopic image of the basket catheter and the angiographic catheter both positioned in the LSPV trough transseptal catheterisation in antero-posterior view during angiography. This projection allows us to further assess catheter positioning and contact inside the vein, an homogeneous distribution of all the splines around the vein perimeter and the position of spline A (identified by single radiopaque marker)

5 Figure 4: Fluoroscopic image of the left inferior pulmonary vein (LIPV) in anteroposterior view. The angiographic catheter is positioned in the vein through transseptal catheterisation Figure 5: Fluoroscopic image of the basket catheter positioning in the same vein and patient as in Figure 4 in anteroposterior view before venography Figure 6: Fluoroscopic image of the right superior pulmonary vein (RSPV) in antero-posterior view. The angiographic catheter is positioned in the vein through transseptal catheterisation Figure 7: Fluoroscopic image of the basket catheter positioning in the same vein and patient as in Figure 6 in antero-posterior view before venography Figure 8: Fluoroscopic image of the basket catheter and the angiographic catheter both positioned in the RSPV trough transseptal catheterisation in antero-posterior view during angiography. This projection allows us to further assess catheter positioning and contact inside the vein, an homogeneous distribution of all the splines around the vein perimeter and the position of spline A (identified by

6 single radiopaque marker) Figure 9: Fluoroscopic image of the basket catheter positioning in the LSPV in antero -posterior view. The angiographic catheter is positioned in the left atrial appendage. This could. Figure 10: Right superior pulmonary vein electrical isolation procedure. From top to bottom, surface ECG lead 3 is displayed together with the recordings of the distal coronary sinus (CSd) and of 3 series of 8 circumferential bipoles (1-2, 2-3, 3-4, etc) obtained from different basket cross-sections (distal: BTD, mid: BTM, proximal: BTP). In the first beat of the sequence, sharp, high amplitude PVs electrograms are recorded. During RF energy application, LA-PV activity dissociation (5th beat) was preceded by a gradual prolongation (arrows) of the LA -PV conduction time (2nd to 4th beats) References 1. Konings KT, Kirchhof CJ, Smeets JR, et al. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994; 89: Chen MC, Guo GB, Chang JP, et al. Radiofrequency and cryoablation of atrial fibrillation in patients undergoing valvular operations. Ann Thorac Surg 1998; 65 (6): Sueda T, Nagata H, Orihashi K, et al. Efficacy of a simple left atrial procedure for chronic atrial fibrillation in mitral valve operations. Ann Thorac Surg 1997; 63 (4): Gaita F, Gallotti R, Calo L, et al. Limited posterior left atrial cryoablation in patients with chronic atrial fibrillation undergoing valvular heart surgery. J Am Coll Cardiol 2000; 36 (1): Jaïs P, Haïssaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999; 100: Haïssaguerre M, Shah DC, Jaïs P, et al. Electrophysiological breakthroughs form the left atrium to the pulmonary veins. Circulation 2000; 102: Natale A, Pisano E, Shewchik J, et al. First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation 2000; 102: Pappone C, Rosario S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary veins ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000; 102: Haïssaguerre M, Jaïs P, Shah DC, et al. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1997; 7: Swartz JF, Pellersels G, Silvers J, et al. A catheter-based curative approach to atrial fibrillation in humans (abstract) Circulation 1994; 90 pt II; I: Saito T, Waki K, Becker AE. Left atrial myocardial extension onto pulmonary veins in humans: anatomic observations relevant for atrial arrhythmias. J Cardiovasc Electrophysiol 2000; 11: Jaïs P, Hocini M, Macle L, et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002; 106: Sueda T, Nagata H, Orihashi K, et al. Efficacy of a simple left atrial procedure for chronic atrial fibrillation in mitral valve operations. Ann Thorac Surg 1997; 63: Zipes DP, Knope RF. Electrical properties of the thoracic veins. Am J Cardiol 1972; 29: Cheung DW. Electrical activity of the pulmonary veins and its interaction with the right atrium in the guinea-pig. J Physiol

7 1981; 314: Haïssaguerre M, Shah DC, Jaïs P, et al. Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. Am J Cardiol 2000; 86: K9-K Spach MS. Anisotropy of cardiac tissue: a major determinant of conduction? J Cardiovasc Electrophysiol 1999; 10: Ho SY, Sanchez-Quintana D, Cabrera JA, et al. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1999; 10: Tada H, Oral H, Wasmer K, et al. Pulmonary vein isolation: comparison of bipolar and unipolar electrograms at successful and unsuccessful ostial ablation sites. J Cardiovasc Electrophysiol 2002; 13: De Ponti R, Tritto M, Lanzotti M, et al. Computerized high-density mapping of the pulmonary veins: new insights into their electrical activation in patients with atrial fibrillation. Europace in press 23. Haïssaguerre M, Jaïs P, Shah DC, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: Tritto M, De Ponti R, Zardini M, et al. Electrical connections between pulmonary veins in humans. Circulation 2001; 104: e Tritto M, De Ponti R, Zardini M, et al. La recidiva precoce di fibrillazione atriale dopo isolamento delle vene polmonari non è necessariamente predittiva di ulteriori ricorrenze aritmiche al follow-up. Ital Heart J 2002; vol 3, suppl 7, C Tritto M, De Ponti, R, Spadacini G, et al. Effects of adenosine on pulmonary vein musculature electrical activity and atriovenous conduction after ostial isolation of the pulmonary veins (submitted for publication) 27. Ho SY, Cabrera JA, Tran VH, Farrè J, et al. Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart 2001; 86: De Ponti R, Tritto M, Spadacini G, et al. Evaluation of atrial propagation by electroanatomic mapping in patients with idiopathic paroxysmal atrial fibrillation versus control patients. Eur Heart J 2002; vol 23, abstract suppl: P Oral H, Knight B, Ozaydin M, et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation. Feasibility and mechanistic insights. Circulation 2002; 106: Oral H, Knight B, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105: Tritto M, De Ponti R, Spadacini G, et al. Isolamento elettrico delle vene polmonari guidato dal mappaggio ad alta densità in pazienti con fibrillazione atriale: fattibilità, efficacia in acuto e potenziali implicazioni della metodica. Ital Heart J 2002; vol 3; suppl 7: P327 Your questions, contributions and commentaries will be answered by the lecturer or experts on the subject in the Arrhythmias list. Please fill in the form and press the "Send" button. Question, contribution or commentary: Name and Surname:: Country:: Argentina Send Erase Top Updating: 09/08/2003

Ablation For Atrial Fibrillation. Bill Petrellis Electrophysiologist

Ablation For Atrial Fibrillation. Bill Petrellis Electrophysiologist Ablation For Atrial Fibrillation Bill Petrellis Electrophysiologist AF is the most common arrhythmia in the Western world Prevalence 1.1% in Australia conservative estimate - 240,000 June 2009 AF is an

More information

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence

More information

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate

More information

DIU de rythmologie et stimulation cardiaque. Orateur : Serge BOVEDA Le 25 janvier 2012

DIU de rythmologie et stimulation cardiaque. Orateur : Serge BOVEDA Le 25 janvier 2012 DIU de rythmologie et stimulation cardiaque Titre : Fibrillation atriale paroxystique : ablation, résultats, complications Orateur : Serge BOVEDA Le 25 janvier 2012 Fibrillation Atriale Paroxystique :

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Catheter Ablation as a Treatment for Atrial Fibrillation File Name: Origination: Last CAP Review: Next CAP Review: Last Review: catheter_ablation_as_a_treatment_for_atrial_fibrillation

More information

Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation. Ashkan Babaie MD Providence Portland Medical Center

Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation. Ashkan Babaie MD Providence Portland Medical Center Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation Ashkan Babaie MD Providence Portland Medical Center 1 Disclosures None 2 Cox-Maze III The Godfather Cure rates > 95% in

More information

The Decision Tree for Ablation Therapy in Atrial Fibrillation Colin Movsowitz, MD, FACC Cardiology Consultants of Philadelphia Director of Electrophysiology Einstein Medical Center Montgomery Co-Director

More information

How should we treat atrial fibrillation in heart failure

How should we treat atrial fibrillation in heart failure Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città

More information

Succesful Radiofrequency Ablation of Atrial Tachycardia Arising From Within the Coronary Venous Sinus

Succesful Radiofrequency Ablation of Atrial Tachycardia Arising From Within the Coronary Venous Sinus Succesful Radiofrequency Ablation of Atrial Tachycardia Arising From Within the Coronary Venous Sinus The Harvard community has made this article openly available. Please share how this access benefits

More information

Presenter Disclosure Information

Presenter Disclosure Information 2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.

More information

1547-5271/$ -see front matter 2007 by the Heart Rhythm Society and the European Heart Rhythm Association,

1547-5271/$ -see front matter 2007 by the Heart Rhythm Society and the European Heart Rhythm Association, HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up A report of the Heart Rhythm Society (HRS)

More information

Atrial fibrillation (AF) is a common arrhythmia associated

Atrial fibrillation (AF) is a common arrhythmia associated Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia A New Anatomic Approach for Curing Atrial Fibrillation Carlo Pappone, MD, PhD; Salvatore Rosanio, MD, PhD; Giuseppe Oreto, MD; Monica Tocchi,

More information

Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center

Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Introduction to Electrophysiology Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Objectives Indications for EP Study How do we do the study Normal recordings Abnormal Recordings Limitations

More information

Surgeons Role in Atrial Fibrillation

Surgeons Role in Atrial Fibrillation Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Catheter Ablation as Treatment Page 1 of 29 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Catheter Ablation as Treatment Professional Institutional Original Effective

More information

Treatments to Restore Normal Rhythm

Treatments to Restore Normal Rhythm Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey

Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey Europace (215) 17, 1596 16 doi:1.19/europace/euv2 EP WIRE Current techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey Nikolaos Dagres 1 *, Maria Grazia

More information

Anatomy of the left atrium and pulmonary veins

Anatomy of the left atrium and pulmonary veins CHAPTER 1 Anatomy of the left atrium and pulmonary veins Hugh Calkins, Siew Y. Ho, José Angel Cabrera, Paolo Della Bella, Jeronimo Farré, Josep Kautzner, Patrick Tchou Introduction Over the past five years,

More information

Management of Symptomatic Atrial Fibrillation

Management of Symptomatic Atrial Fibrillation Management of Symptomatic Atrial Fibrillation John F. MacGregor, MD, FHRS Associate Medical Director, Cardiac Electrophysiology PeaceHealth St. Joseph Medical Center, Bellingham, WA September 18, 2015

More information

Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation

Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation Policy Number: Original Effective Date: MM.06.011 09/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration

More information

Management of Pacing Wires After Cardiac Surgery

Management of Pacing Wires After Cardiac Surgery Management of Pacing Wires After Cardiac Surgery David E. Lizotte, Jr. PA C, MPAS, FAPACVS President, Association of Physician Assistants in Cardiovascular Surgery Conflicts: None Indications 2008 Journal

More information

Atrial Fibrillation and Ablation Therapy: A Patient s Guide

Atrial Fibrillation and Ablation Therapy: A Patient s Guide Atrial Fibrillation and Ablation Therapy: A Patient s Guide ATRIAL FIBRILLATION CENTER AT UNIVERSITY OF ROCHESTER MEDICAL CENTER www.heart.urmc.edu 585-275-4775 INTRODUCTION Our goal at the Atrial Fibrillation

More information

Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation

Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation Policy #: 283 Latest Review Date: June 2015 Category: Medical Policy Grade: A Background/Definitions:

More information

Tachyarrhythmias (fast heart rhythms)

Tachyarrhythmias (fast heart rhythms) Patient information factsheet Tachyarrhythmias (fast heart rhythms) The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): April 26, 2011 Most Recent Review Date (Revised): January 27, 2015 Effective Date: April 1, 2015 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

CATHETER ABLATION for ATRIAL FIBRILLATION

CATHETER ABLATION for ATRIAL FIBRILLATION CATHETER ABLATION for ATRIAL FIBRILLATION Atrial Fibrillation Clinic Dr. Richard Leather, Dr. Larry Sterns, Dr Paul Novak, Dr. Chris Lane Royal Jubilee Hospital Block 3 rd floor, Rm 343 1952 Bay Street

More information

Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial

Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial Lucas Boersma, WimJan van Boven, Alaaddin Yilmaz, Johannes Kelder, Maurits Wijffels

More information

Atrial Fibrillation in the Wolff-Parkinson-White Syndrome. John Whitaker, Conn Sugihara and Michael Cooklin (Guy s and St Thomas NHS Foundation Trust)

Atrial Fibrillation in the Wolff-Parkinson-White Syndrome. John Whitaker, Conn Sugihara and Michael Cooklin (Guy s and St Thomas NHS Foundation Trust) Atrial Fibrillation in the Wolff-Parkinson-White Syndrome John Whitaker, Conn Sugihara and Michael Cooklin (Guy s and St Thomas NHS Foundation Trust) A 38 year old paramedic was admitted with symptoms

More information

Radiofrequency ablation of atrial tachycardia from no man s land

Radiofrequency ablation of atrial tachycardia from no man s land CASE REPORT 103 A case of atrial tachycardia originating between the His region and the non-coronary cusp Radiofrequency ablation of atrial tachycardia from no man s land Nikola Pavlović a,b, Sven Knecht

More information

DISCLOSURE. Atrial Fibrillation Management An Evidence-based Approach OBJECTIVES BACKGROUND AFFIRM 9/16/2015

DISCLOSURE. Atrial Fibrillation Management An Evidence-based Approach OBJECTIVES BACKGROUND AFFIRM 9/16/2015 Death (%) Mortality (%) 9/16/2015 DISCLOSURE Atrial Fibrillation Management An Evidence-based Approach Jonathon Adams, MD, FHRS Relevant Financial Relationship(s) None Off Label Usage None OBJECTIVES What

More information

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation An update on diagnosis and management Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.

More information

Practical class 3 THE HEART

Practical class 3 THE HEART Practical class 3 THE HEART OBJECTIVES By the time you have completed this assignment and any necessary further reading or study you should be able to:- 1. Describe the fibrous pericardium and serous pericardium,

More information

Patient Information Sheet Electrophysiological study

Patient Information Sheet Electrophysiological study Patient Information Sheet Electrophysiological study Your doctor has recommended performing an electrophysiological study (also called EPS). EPS is a diagnostic procedure designed to test and evaluate

More information

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia

More information

Distance Learning Program Anatomy of the Human Heart/Pig Heart Dissection Middle School/ High School

Distance Learning Program Anatomy of the Human Heart/Pig Heart Dissection Middle School/ High School Distance Learning Program Anatomy of the Human Heart/Pig Heart Dissection Middle School/ High School This guide is for middle and high school students participating in AIMS Anatomy of the Human Heart and

More information

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Atrial Fibrillation The Basics

Atrial Fibrillation The Basics Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation

More information

Techniques of Mapping and Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation

Techniques of Mapping and Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation Aus dem Deutschen Herzzentrum Berlin Klinik für Innere Medizin/Kardiologie DISSERTATION Techniques of Mapping and Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation zur Erlangung des

More information

Atrial Fibrillation (AF) Explained

Atrial Fibrillation (AF) Explained James Paget University Hospitals NHS Foundation Trust Atrial Fibrillation (AF) Explained Patient Information Contents What are the symptoms of atrial fibrillation (AF)? 3 Normal heartbeat 4 How common

More information

How do you decide on rate versus rhythm control?

How do you decide on rate versus rhythm control? Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study

More information

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015 Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.

More information

Recurrent AF: Choosing the Right Medication.

Recurrent AF: Choosing the Right Medication. In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department

More information

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated

More information

Cardiac Masses and Tumors

Cardiac Masses and Tumors Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:

More information

National Medical Policy

National Medical Policy National Medical Policy Subject: Policy Number: Catheter Ablation for Atrial Fibrillation NMP175 Effective Date*: May 2010 Update: July 2015 This National Medical Policy is subject to the terms in the

More information

2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them?

2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? 2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? Gaetano Senatore DIVISION OF CARDIOLOGY HOSPITAL OF CIRIE

More information

Atrial Fibrillation (AF) March, 2013

Atrial Fibrillation (AF) March, 2013 Atrial Fibrillation (AF) March, 2013 This handout is meant to help with discussions about the condition, and it is not a complete discussion of AF. We hope it will complement your appointment with one

More information

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.

More information

Anatomi & Fysiologi 060301. The cardiovascular system (chapter 20) The circulation system transports; What the heart can do;

Anatomi & Fysiologi 060301. The cardiovascular system (chapter 20) The circulation system transports; What the heart can do; The cardiovascular system consists of; The cardiovascular system (chapter 20) Principles of Anatomy & Physiology 2009 Blood 2 separate pumps (heart) Many blood vessels with varying diameter and elasticity

More information

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise WEEK 3 SUPPLEMENT HEART HEALTH A Beginner s Guide to Cardiovascular Disease HEART FAILURE Heart failure can be defined as the failing (insufficiency) of the heart as a mechanical pump due to either acute

More information

GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS

GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS 65 G E R I A T R I A 2011; 5: 65-69 GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS Otrzymano/Submitted: 24.02.2011 Poprawiono/Corrected: 01.03.2011 Zaakceptowano/Accepted: 06.03.2011 Akademia

More information

Advanced Treatment for Chronic Atrial Fibrillation

Advanced Treatment for Chronic Atrial Fibrillation Advanced Treatment for Chronic Atrial Fibrillation Montefiore Einstein Heart Center New York City, NY April 1, 2009 Welcome to this OR Live webcast presentation, live Montefiore Einstein Heart Center in

More information

Catheter Ablation. A Guided Approach for Treating Atrial Arrhythmias

Catheter Ablation. A Guided Approach for Treating Atrial Arrhythmias Catheter Ablation A Guided Approach for Treating Atrial Arrhythmias A P A T I E N T H A N D B O O K This brochure will provide an overview of atrial arrhythmias (heart rhythm problems affecting the upper

More information

Publicaties. A.C. Linnenbank

Publicaties. A.C. Linnenbank Publicaties A.C. Linnenbank [1] M. J. van der Horst, A. C. Linnenbank, W. A. Serdijn, and J. R. Long, Systematic design of a transimpedance amplifier with specified electromagnetic out-of-band interference

More information

Atrioventricular (AV) node ablation

Atrioventricular (AV) node ablation Patient information factsheet Atrioventricular (AV) node ablation The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout

More information

Note: The left and right sides of the heart must pump exactly the same volume of blood when averaged over a period of time

Note: The left and right sides of the heart must pump exactly the same volume of blood when averaged over a period of time page 1 HEART AS A PUMP A. Functional Anatomy of the Heart 1. Two pumps, arranged in series a. right heart: receives blood from the systemic circulation (via the great veins and vena cava) and pumps blood

More information

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of

More information

Diagnostic Electrophysiology & Ablation

Diagnostic Electrophysiology & Ablation Limited Ablation for Persistent Atrial Fibrillation Using Preprocedure Reverse Remodelling David Slotwiner 1 and Jonathan Steinberg 2 1. Assistant Professor of Cardiology, Hofstra North Shore-LIJ School

More information

Heart and Vascular System Practice Questions

Heart and Vascular System Practice Questions Heart and Vascular System Practice Questions Student: 1. The pulmonary veins are unusual as veins because they are transporting. A. oxygenated blood B. de-oxygenated blood C. high fat blood D. nutrient-rich

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

Electrodes placed on the body s surface can detect electrical activity, APPLIED ANATOMY AND PHYSIOLOGY. Circulatory system

Electrodes placed on the body s surface can detect electrical activity, APPLIED ANATOMY AND PHYSIOLOGY. Circulatory system 4 READING AND INTERPRETING THE ELECTROCARDIOGRAM Electrodes placed on the body s surface can detect electrical activity, which occurs in the heart. The recording of these electrical events comprises an

More information

Advances in the Treatment of Atrial Fibrillation At VCU Medical Center

Advances in the Treatment of Atrial Fibrillation At VCU Medical Center Contact Us For additional information or to schedule an appointment with one of our specialists, please call: Ken Ellenbogen, M.D. Cardiology/Electrophysiology 804-828-7565 or 804-628-0147 You can also

More information

Atrial Fibrillation Peter Santucci, MD Revised May, 2008

Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is

More information

Atrial Fibrillation : Present Treatment Protocols by Drugs and Interventions

Atrial Fibrillation : Present Treatment Protocols by Drugs and Interventions UPDATE ARTICLE JIACM 2003; 4(3): 213-27 Atrial Fibrillation : Present Treatment Protocols by Drugs and Interventions Indranill Basu Ray* Abstract Atrial fibrillation is the commonest arrhythmia encountered

More information

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. Exam Name MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. 1) What term is used to refer to the process of electrical discharge and the flow of electrical

More information

Visited 9/14/2011. What is Atrial Fibrillation? What you need to know about Atrial Fibrillation. The Normal Heart Rhythm. 1 of 7 9/14/2011 10:50 AM

Visited 9/14/2011. What is Atrial Fibrillation? What you need to know about Atrial Fibrillation. The Normal Heart Rhythm. 1 of 7 9/14/2011 10:50 AM 1 of 7 9/14/2011 10:50 AM Current URL: What you need to know about Atrial Fibrillation What is atrial fibrillation? What causes atrial fibrillation? How is atrial fibrillation diagnosed? What are the dangers

More information

TABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)

TABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours) Clinical Practice Guidelines for the Management of Patients With Atrial Fibrillation Deborah Ritchie RN, MN, Robert S Sheldon MD, PhD Cardiovascular Research Group, University of Calgary, Alberta Partly

More information

Managing the Patient with Atrial Fibrillation

Managing the Patient with Atrial Fibrillation Pocket Guide Managing the Patient with Atrial Fibrillation Updated April 2012 Editor Stephen R. Shorofsky, MD, Ph.D. Assistant Editors Anastasios Saliaris, MD Shawn Robinson, MD www.hrsonline.org DEFINITION

More information

Electrophysiology study (EPS)

Electrophysiology study (EPS) Patient information factsheet Electrophysiology study (EPS) The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout

More information

Ngaire has Palpitations

Ngaire has Palpitations Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.

More information

Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE

Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE Rome, Italy December 4-7, 2012 Rome Cavalieri Monday, December 3 ROOM Terrazza Monte Mario PATIENT MANAGEMENT CONCEPTS AND CONTROVERSIES IN ELECTROPHYSIOLOGY BIOTRONIK International Fellows Program (IFP)

More information

HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)

HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs) HTEC 91 Medical Office Diagnostic Tests Week 4 Topic for Today: Atrial Rhythms PACs: Premature Atrial Contractions PAT: Paroxysmal Atrial Tachycardia AF: Atrial Fibrillation Atrial Flutter Premature Atrial

More information

Synopsis of Causation

Synopsis of Causation Ministry of Defence Synopsis of Causation Atrial Fibrillation Author: Dr Douglas Dingwall, Medical Author, Medical Text, Edinburgh Validator: Professor Gregory Y H Lip, City Hospital, Birmingham September

More information

Electrocardiographic recognition and ablation of outflow tract ventricular tachycardia

Electrocardiographic recognition and ablation of outflow tract ventricular tachycardia VIEWPOINT Electrocardiographic recognition and ablation of outflow tract ventricular tachycardia Rupa Bala, MD, Francis E. Marchlinski, MD From the Hospital of the University of Pennsylvania, Philadelphia,

More information

Management of Atrial Fibrillation in Heart Failure

Management of Atrial Fibrillation in Heart Failure Disadvantages of AV Junction Ablation Persistent AFib- no AV synchrony Ongoing risk of thromboembolism Life-long dependency on pacemaker Comparison of LA Ablation vs. AVN Ablation LA Ablation AVN Ablation

More information

Il destino dei pazienti dopo ablazione della fibrillazione atriale

Il destino dei pazienti dopo ablazione della fibrillazione atriale Tigullio Cardiologia 2014 La terapia della fibrillazione atriale: Il destino dei pazienti dopo ablazione della fibrillazione atriale N. Bottoni Responsabile U.O.S. Aritmologia Interventistica, Az. Ospedaliera

More information

ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014

ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014 ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014 Facts 4 million or so people have atrial fibrillation 16 billion dollars spent yearly in USA 30% of strokes attributable to AF and AFL 3-5

More information

Electrocardiography I Laboratory

Electrocardiography I Laboratory Introduction The body relies on the heart to circulate blood throughout the body. The heart is responsible for pumping oxygenated blood from the lungs out to the body through the arteries and also circulating

More information

Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin

Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin B. Keweloh 16.11.2013 Incidence of Atrial Fibrillation, Standard population

More information

Patient Information Leaflet about Pradaxa for Atrial Fibrillation. You Have Been Prescribed Pradaxa

Patient Information Leaflet about Pradaxa for Atrial Fibrillation. You Have Been Prescribed Pradaxa Patient Information Leaflet about Pradaxa for Atrial Fibrillation You Have Been Prescribed Pradaxa Your doctor has prescribed Pradaxa for you. The purpose of the medication is to minimise the risk that

More information

How do you decide on rate versus rhythm control?

How do you decide on rate versus rhythm control? How do you decide on rate versus rhythm control? Dr. Mark O Neill Consultant Cardiologist & Electrophysiologist Assumptions Camm et al. EHJ 2010;Sept 25 epub Choice of strategy: Criteria for consideration

More information

INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES

INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES NOTICE: This is an introductory guide for a user to understand basic ECG tracings and parameters. The guide will allow user to identify some of the

More information

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter 22 July 2010 EMA/CHMP/EWP/213056/2010 Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter Draft Agreed by Efficacy Working Party July 2008 Adoption by CHMP for release

More information

9/5/14. Objectives. Atrial Fibrillation (AF)

9/5/14. Objectives. Atrial Fibrillation (AF) Novel Anticoagulation for Prevention of Stroke in Patients with Atrial Fibrillation Objectives 1. Review current evidence on use of warfarin in individuals with atrial fibrillation 2. Compare the three

More information

Treatment Strategy for Atrial Fibrillation

Treatment Strategy for Atrial Fibrillation Rhythm or rate control in persistent atrial fibrillation Peter G. Guerra, Denis Roy Department of Medicine and Research Center, Montreal Heart Institute, Montreal, Quebec, Canada Selecting appropriate

More information

Comparison of bipolar and unipolar programmed electrical stimulation for the initiation of ventricular arrhythmias: significance of anodal excitation

Comparison of bipolar and unipolar programmed electrical stimulation for the initiation of ventricular arrhythmias: significance of anodal excitation DIAGNOSTIC METHODS ELECTROPHYSIOLOGY Comparison of bipolar and unipolar programmed electrical stimulation for the initiation of ventricular arrhythmias: significance of anodal excitation during bipolar

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Subclavian Steal Syndrome By Marta Thorup

Subclavian Steal Syndrome By Marta Thorup Subclavian Steal Syndrome By Marta Thorup Definition Subclavian steal syndrome (SSS), is a constellation of signs and symptoms that arise from retrograde flow of blood in the vertebral artery, due to proximal

More information

Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies

Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies SYMPOSIUM ON CARDIOVASCULAR MANAGEMENT OF ATRIAL DISEASES FIBRILLATION Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies MARK A. CRANDALL, MD;

More information

2 Clinical Cardiac Electrophysiology

2 Clinical Cardiac Electrophysiology 2 Clinical Cardiac Electrophysiology Andrew C. Rankin F. Russell Quinn Alan P. Rae 2.1 Introduction... 54 2.2 History of Clinical Electrophysiology... 54 2.3 Methodology... 55 2.3.1 Electrophysiological

More information

Atrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy

Atrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy Cardiac rate control or rhythm control could be the key to AF therapy Recent studies have proven that an option of pharmacologic and non-pharmacologic therapy is available to patients who suffer from AF.

More information

A Patient Guide to Atrial Fibrillation and Catheter Ablation

A Patient Guide to Atrial Fibrillation and Catheter Ablation A Patient Guide to Atrial Fibrillation and Catheter Ablation Al-Sabah Arrhythmia Institute 1111 Amsterdam Avenue New York, NY 10025 Phone: 212-523-2400 Fax: 212-523-2571 www.stlukescardiology.org Printed

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

Atrial fibrillation. Treatment Guide

Atrial fibrillation. Treatment Guide Treatment Guide Atrial fibrillation Atrial fibrillation (AF or AFib) is the most common irregular or abnormal heart rhythm disorder, affecting more than 3 million Americans today. Thankfully, more options

More information

Clinical Mapping Approach to Diagnose Electrical Rotors and Focal Impulse Sources for Human Atrial Fibrillation

Clinical Mapping Approach to Diagnose Electrical Rotors and Focal Impulse Sources for Human Atrial Fibrillation Clinical Mapping Approach to Diagnose Electrical Rotors and Focal Impulse Sources for Human Atrial Fibrillation SANJIV M. NARAYAN, M.Sc., M.D., Ph.D., DAVID E. KRUMMEN, M.D., and WOUTER-JAN RAPPEL, Ph.D.

More information

Atrial Fibrillation Management Across the Spectrum of Illness

Atrial Fibrillation Management Across the Spectrum of Illness Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,

More information

A focus on atrial fibrillation

A focus on atrial fibrillation A focus on atrial fibrillation Is being female really a risk factor for stroke? Dr Justin Mariani MBBS BMedSci PhD FRACP FCSANZ Consultant Cardiologist and Interventional Heart Failure Specialist Alfred

More information

5 MILLION AMERICANS 1. Atrial Fibrillation (AFib) AFib affects an estimated

5 MILLION AMERICANS 1. Atrial Fibrillation (AFib) AFib affects an estimated A Patient s Guide To with Atrial Fibrillation (AFib) CAUSES RISK FACTORS SYMPTOMS DIAGNOSIS TREATMENTS INSIDE The Healthy Heart... 2 Your Heart In AFib... 4 How Do You Get It?... 6 How Do You Know If You

More information